Cellectis S.A. Purchase Of Interests In Investments Accounted For Using Equity Method
Cellectis S.A. (CLLS) reported Purchase Of Interests In Investments Accounted For Using Equity Method of $140.00 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes
ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod · last filed 2024-04-29
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2023-12-31 | $140.00M 20-F · filed 2024-04-29 |